Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ajay Prakash and Bikash Medhi.
Ajay Prakash
Connection Strength
10.647
Bikash Medhi
  1. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis. Sci Rep. 2021 06 18; 11(1):12888.
    View in: PubMed
    Score: 0.951
  2. Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review. Indian J Pharmacol. 2021 May-Jun; 53(3):236-243.
    View in: PubMed
    Score: 0.943
  3. Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients. Indian J Pharmacol. 2020 Sep-Oct; 52(5):414-421.
    View in: PubMed
    Score: 0.901
  4. Intellectual property rights and Indian pharmaceutical industry: Present scenario. Indian J Pharmacol. 2018 Mar-Apr; 50(2):57-60.
    View in: PubMed
    Score: 0.757
  5. Update on geographical variation and distribution of SARS-nCoV-2: A systematic review. Indian J Pharmacol. 2021 Jul-Aug; 53(4):310-316.
    View in: PubMed
    Score: 0.238
  6. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Indian J Pharmacol. 2021 Jul-Aug; 53(4):317-327.
    View in: PubMed
    Score: 0.238
  7. Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review. Phytother Res. 2021 Aug; 35(8):4456-4484.
    View in: PubMed
    Score: 0.238
  8. Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors "leflunomide" and "teriflunomide" in Covid-19: A narrative review. Eur J Pharmacol. 2021 Sep 05; 906:174233.
    View in: PubMed
    Score: 0.237
  9. Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD. Comput Biol Med. 2021 07; 134:104495.
    View in: PubMed
    Score: 0.236
  10. Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings. J Biomol Struct Dyn. 2021 May 13; 1-11.
    View in: PubMed
    Score: 0.236
  11. Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak. Indian J Pharmacol. 2021 May-Jun; 53(3):187-191.
    View in: PubMed
    Score: 0.236
  12. Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable? Med Hypotheses. 2021 Apr; 149:110539.
    View in: PubMed
    Score: 0.233
  13. Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review. Biomed Pharmacother. 2021 May; 137:111300.
    View in: PubMed
    Score: 0.232
  14. Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review. Tissue Cell. 2021 Jun; 70:101497.
    View in: PubMed
    Score: 0.232
  15. Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacol Rep. 2021 Jun; 73(3):736-749.
    View in: PubMed
    Score: 0.230
  16. Indian contribution toward biomedical research and development in COVID-19: A systematic review. Indian J Pharmacol. 2021 Jan-Feb; 53(1):63-72.
    View in: PubMed
    Score: 0.230
  17. Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study. Int J Antimicrob Agents. 2020 Dec; 56(6):106224.
    View in: PubMed
    Score: 0.228
  18. Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis. Indian J Pharmacol. 2020 Nov-Dec; 52(6):535-550.
    View in: PubMed
    Score: 0.228
  19. In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations. mSystems. 2020 Sep 22; 5(5).
    View in: PubMed
    Score: 0.226
  20. Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence. Vet Res Commun. 2020 Nov; 44(3-4):119-130.
    View in: PubMed
    Score: 0.226
  21. Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. J Mol Graph Model. 2020 12; 101:107716.
    View in: PubMed
    Score: 0.225
  22. Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review. Life Sci. 2020 Oct 01; 258:118207.
    View in: PubMed
    Score: 0.224
  23. Pattern of clinical research in the era of COVID-19 pandemic: A new learning experience for the present as well as future. Indian J Pharmacol. 2020 Jul-Aug; 52(4):249-253.
    View in: PubMed
    Score: 0.223
  24. Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis. Indian J Pharmacol. 2020 Jul-Aug; 52(4):313-323.
    View in: PubMed
    Score: 0.223
  25. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virol Sin. 2020 Jun; 35(3):290-304.
    View in: PubMed
    Score: 0.222
  26. Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown. Indian J Pharmacol. 2020 Mar-Apr; 52(2):75-78.
    View in: PubMed
    Score: 0.221
  27. COVID-19 pandemic: A review based on current evidence. Indian J Pharmacol. 2020 Mar-Apr; 52(2):117-129.
    View in: PubMed
    Score: 0.221
  28. Update on the target structures of SARS-CoV-2: A systematic review. Indian J Pharmacol. 2020 Mar-Apr; 52(2):142-149.
    View in: PubMed
    Score: 0.221
  29. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). J Biomol Struct Dyn. 2021 05; 39(8):2724-2732.
    View in: PubMed
    Score: 0.221
  30. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. J Med Virol. 2020 07; 92(7):776-785.
    View in: PubMed
    Score: 0.220
  31. Biovigilance: A Global Perspective. Perspect Clin Res. 2019 Oct-Dec; 10(4):155-162.
    View in: PubMed
    Score: 0.211
  32. Modulation of endocannabinoid system: Success lies in the failures. Indian J Pharmacol. 2018 Jul-Aug; 50(4):155-158.
    View in: PubMed
    Score: 0.194
  33. Comparative effect of manuka honey on anaerobic parasitic protozoans with standard drug therapy under in vitro conditions: A preliminary study. Indian J Pharmacol. 2018 Jul-Aug; 50(4):197-203.
    View in: PubMed
    Score: 0.194
  34. Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy. Indian J Pharmacol. 2018 Jan-Feb; 50(1):1-3.
    View in: PubMed
    Score: 0.187
  35. Three-dimensional drugs: A new era in the pharmaceutical development. Indian J Pharmacol. 2017 Nov-Dec; 49(6):417-418.
    View in: PubMed
    Score: 0.185
  36. Congenital malformation and autism spectrum disorder: Insight from a rat model of autism spectrum disorder. Indian J Pharmacol. 2017 May-Jun; 49(3):243-249.
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.